Skip to content

Prevalence of Intracranial Aneurysm in Hong Kong Chinese

Prevalence of Intracranial Aneurysm in Hong Kong Chinese

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01078506
Enrollment
200
Registered
2010-03-02
Start date
2010-01-31
Completion date
2013-01-31
Last updated
2013-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intracranial Aneurysm

Keywords

Chinese, intracranial aneurysm, magnetic resonance imaging

Brief summary

Intracranial aneurysm (localized dilatation in weakened blood vessel wall) rupture is a catastrophic disease, with half of the victims died and many of the survivors disabled. There is currently no data in the literature for the Chinese population concerning the prevalence, characteristics (location and size) and risk of harboring an unruptured intracranial aneurysm. In this study, the investigators aim to study the population prevalence and characteristics (location and size) of intracranial aneurysm in Hong Kong Chinese, and its cost-effectiveness. The screening is carried out using magnetic resonance angiography (MRA), with a 3-T magnetic resonance system, which is a well-established non-invasive method for intracranial aneurysm detection.

Detailed description

As charted below.

Interventions

None listed

Sponsors

Chinese University of Hong Kong
Lead SponsorOTHER

Study design

Observational model
ECOLOGIC_OR_COMMUNITY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
21 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy adults aged between 21 and 65 years

Exclusion criteria

* Contraindications to MRI * History of known intracranial pathologies

Design outcomes

Primary

MeasureTime frame
Intracranial aneurysmThree years

Secondary

MeasureTime frame
Other intracranial pathologiesThree years

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026